Article
Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics.
Brain pathology (Zurich, Switzerland) - 1 Jul 2013
Appin Christina L, Gao Jingjing, Chisolm Candace, Torian Mike, Alexis Dianne, Vincentelli Cristina, Schniederjan Matthew J, Hadjipanayis Costas, Olson Jeffrey J, Hunter Stephen, Hao Chunhai, Brat Daniel J
Abstract excerpt
Glioblastoma (GBM) is an aggressive primary brain tumor with an average survival of approximately 1 year. A recently recognized subtype, glioblastoma with oligodendroglioma component (GBM-O), was designated by the World Health Organization (WHO) in 2007. We investigated GBM-Os for their clinical and molecular characteristics as compared to other forms of GBM. Tissue samples were used to determine EGFR, PTEN, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
